TCI Biotech to Unveil New Vision at Vitafoods Europe 2025: CDMO+, High-Absorption Innovation, and 45 Years of Scientific Leadership
BARCELONA, Spain, May 19, 2025 /PRNewswire/ -- TCI Biotech, a global leader in health and wellness innovation, will mark a major milestone at Vitafoods Europe 2025 with a dynamic showcase of its rebranded identity, next-gen CDMO+ model, and advanced nutritional technologies. Located at booth #3G6, TCI's exhibition will spotlight how science, technology, and consumer insight converge to shape the...
VITAMIN ANGELS AND THE MINISTRY OF HEALTH OF INDONESIA HOST MMS MEETING WITH LEADING NATIONAL AND GLOBAL EXPERTS TO REVIEW PROGRESS ON INDONESIA’S “NATIONAL MMS ANTENATAL PROGRAM”
As one of the first countries to implement an end-to-end initiative to integrate MMS and nutrition training into its national health care system, Indonesia aims to reach 4.8 million pregnant women with MMS by 2026 BOGOR, Indonesia, May 19, 2025 /PRNewswire/ -- Vitamin Angels and the Ministry of Health...
CooperVision to Host 5th Asia-Pacific Myopia Management Symposium (APMMS) Alongside Events in the Region
APMMS 2025 is held in partnership with The Hong Kong Association Private Practice Optometrists and The Hong Kong Society of Professional Optometrists and supported by The World Council of Optometry and The World Society of Paediatric Ophthalmology and Strabismus. This year's symposium and surrounding events will focus on elevating paediatric myopia...
AIM Vaccine’s Next-Gen mRNA Shingles Vaccine Secures Clinical Approvals in Both PRC and U.S. ,mRNA Platform Advantages Shine Through
HONG KONG, May 19, 2025 /PRNewswire/ -- While global giants like Moderna and BioNTech apply mRNA technology to broader disease markets, PRC's mRNA frontrunner is keeping pace. AIM Vaccine (06660.HK), a leading domestic vaccine company, announced today that its self-developed mRNA shingles vaccine has received clinical trial approval from PRC's Center for Drug Evaluation (CDE), following its U.S....
Innovent Released 2024 ESG Report, Underscoring Commitment to Sustainable Development and Global Innovation
SAN FRANCISCO and SUZHOU, China, May 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces the release of its "2024 Environmental, Social and Governance (ESG) Report", highlighting the Company's strategies, actions, and...
Art of Giving: A Global Initiative for Peace and Happiness
BHUBANESWAR, India, May 17, 2025 /PRNewswire/ -- Art of Giving (AOG) is a life philosophy that inspires millions around the globe to practice kindness, compassion, and community engagement. It was conceptualised and led by Prof. Achyuta Samanta, educationist and social reformer. It has become a civic movement dedicated to fostering peace and happiness through selfless giving. The movement is based on...
2025 EASL Congress Spotlight: CG-0416 Preclinical Data Unveils A Groundbreaking Dual-Action Therapy Targeting Obesity and MASH
——A First-in-Class Hydrolysis-Activated Liver-Targeted THR-β Prodrug Demonstrating A Dual Advantage of Fat Reduction and Muscle Preservation SHANGHAI, May 17, 2025 /PRNewswire/ -- At the European Association for the Study of the Liver (EASL) Annual Congress, CureGene Pharmaceuticals ("CureGene") announced late-breaking preclinical results for its investigational liver-targeted thyroid hormone receptor beta (THR-β) prodrug, CG-0416. Presented in a Late-Breaking Poster session,...
SNS812, an innovative siRNA drug from Oneness and Microbio (Shanghai), selected for ATS 2025 oral presentation, demonstrating world-leading clinical outcomes in COVID-19 treatment
TAIPEI, May 16, 2025 /PRNewswire/ -- The broad-spectrum antiviral siRNA drug SNS812, co-developed by Oneness Biotech (4743.TW) and Microbio (Shanghai), has been selected for oral presentation at the prestigious 2025 American Thoracic Society (ATS) International Conference. The presentation will deliver the latest clinical data to leading global experts in the fields of respiratory and infectious diseases. SNS812 is the world's...
CathWorks Announces Key Events for EuroPCR 2025
NEWPORT BEACH, Calif. and AMSTERDAM, May 16, 2025 /PRNewswire/ -- CathWorks, a global leader in digital health innovations, announced today the schedule of key events for the company during the upcoming EuroPCR 2025 conference taking place May 20 to 23 at the Palais des Congrès in Paris, France. CathWorks announces key events for EuroPCR 2025 ...
Visionary: Pioneering a New Era in Cancer Screening
TORONTO, May 16, 2025 /PRNewswire/ -- Recently, Visionary has achieved a significant breakthrough in the field of early cancer screening and home self - testing technologies, attracting widespread attention from the industry. American Precision Biotech Inc. is a subsidiary of Visionary Holdings. Since its establishment in 1996, the company has been dedicated to the research, development, production, and sales of...
